- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06092749
Chronic Unilateral Lumbar Radicular Pain
November 16, 2023 updated by: Ibrahim Mamdouh Esmat, Ain Shams University
Effectiveness of Transgrade vs Interlaminar Epidural Steroid Injection for Chronic Unilateral Lumbar Radicular Pain
Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks.
Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories.
Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ibrahim Mamdouh Esmat
- Phone Number: 01001241928
- Email: ibrahim_mamdouh@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ain-Shams University Hospitals
-
Contact:
- Ibrahim Mamdouh Esmat
- Email: ibrahim_mamdouh@med.asu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- > 6-month history of persistent pain in one leg with back pain.
- Capable of giving informed consent.
- Unsatisfactory response to conventional treatments including physical therapy or medications with a numeric rating scale (NRS) ≥ 5.
Exclusion Criteria:
- Previous lumbar spinal surgery.
- Myelopathy.
- Rheumatoid disorders.
- Psychiatric disorders
- Bleeding or coagulation disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Transgrade technique (TG)
|
Transgrade (TG) Epidural Steroid Injection technique
|
Active Comparator: Interlaminar technique (IL)
|
Interlaminar (IL) Epidural Steroid Injection technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The average numeric rating scale (NRS) pain scores
Time Frame: at 12 weeks after intervention
|
The numeric rating scale (NRS) is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
|
at 12 weeks after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Estimated)
April 30, 2025
Study Completion (Estimated)
April 30, 2025
Study Registration Dates
First Submitted
October 16, 2023
First Submitted That Met QC Criteria
October 16, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Estimated)
November 17, 2023
Last Update Submitted That Met QC Criteria
November 16, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU MD 286/ 2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuropathic Pain
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
University Malaysia SarawakPersatuan Diabetes MalaysiaCompletedNeuropathic Pain, Nociceptive PainMalaysia
-
University Hospital, Strasbourg, FranceTerminatedPostthoracotomy Pain | Postthoracoscopy Neuropathic PainFrance
-
AstraZenecaCompletedNociceptive Pain | Peripheral Neuropathic PainUnited Kingdom
-
University Hospital, Clermont-FerrandRecruitingPeripheral Neuropathic PainFrance
-
Daiichi Sankyo Co., Ltd.CompletedCentral Neuropathic PainJapan, Korea, Republic of, Taiwan
-
Hospices Civils de LyonCompletedPharmacoresistant Neuropathic PainFrance
-
Yuhan CorporationCompletedPeripheral Neuropathic PainKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedNeuropathic Pain RebelFrance
Clinical Trials on Transgrade technique (TG)
-
Kolon TissueGene, Inc.Not yet recruiting
-
Asana BioSciencesCompletedDermatitis, Atopic | Pruritus | Dermatitis EczemaUnited States, Canada
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaTaiwan
-
GPCR Therapeutics, Inc.Completed
-
TG Therapeutics, Inc.Completed
-
TaiGen Biotechnology Co., Ltd.R&G Pharma Studies Co.,Ltd.Completed
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterCompletedChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
TaiGen Biotechnology Co., Ltd.R&G Pharma Studies Co.,Ltd.Completed
-
TaiGen Biotechnology Co., Ltd.CompletedDiabetic Foot InfectionsTaiwan, United States, South Africa, Thailand